Spruce Biosciences SPRB
NASDAQ SPRB
$47.27 -0.24 (-0.51%)
At close: Sep 29, 2026 · 4:00 PM EDT

Spruce Biosciences (SPRB) Share-based Compensation (2019 - 2026)

Updated

Spruce Biosciences (SPRB) posted Share-based Compensation of $871,000 for Q2 2026, compared with -$77,000 a year earlier and up 26.4% from the prior quarter.

Analysis

Spruce Biosciences (SPRB) Share-based Compensation (2019 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Share-based Compensation at Spruce Biosciences was $3.67 million, up 42.8% year-over-year; for FY2025, it came in at $2.57 million, down 51.9% from FY2024.

  • Annual Share-based Compensation shows a five-year compound annual growth rate of 27.8% (FY2020 to FY2025).
  • In prior years, Spruce Biosciences' Share-based Compensation was $5.35 million in FY2024 (+15.7%), $4.62 million in FY2023 (+27.3%), $3.63 million in FY2022 (-8.3%) and $3.96 million in FY2021 (+424.2%).
  • Quarterly Share-based Compensation has run from a low of -$77,000 in Q2 2025 to a high of $1.69 million in Q4 2025 over five years.
  • On a year-over-year basis, Share-based Compensation increased in three of the last six quarters, with an average decline of 7.6%.
  • The strongest year-over-year quarter for Share-based Compensation in the past five years was Q3 2021, with growth of 372.9%; the weakest was Q1 2025, with a decline of 65.2%.
  • According to Business Quant data, Share-based Compensation for the three prior quarters was $689,000 (Q1 2026), $1.69 million (Q4 2025) and $415,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Spruce Biosciences 130.79 Mn 130.79 Mn - 871,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 871,000.00
Mar 31, 2026 689,000.00
Dec 31, 2025 1.69 Mn
Sep 30, 2025 415,000.00
Jun 30, 2025 -77,000.00
Mar 31, 2025 544,000.00
Dec 31, 2024 961,000.00
Sep 30, 2024 1.14 Mn
Jun 30, 2024 1.69 Mn
Mar 31, 2024 1.56 Mn
Dec 31, 2023 1.22 Mn
Sep 30, 2023 1.12 Mn
Jun 30, 2023 1.22 Mn
Mar 31, 2023 1.06 Mn
Dec 31, 2022 802,000.00
Sep 30, 2022 783,000.00
Jun 30, 2022 905,000.00
Mar 31, 2022 1.14 Mn
Dec 31, 2021 797,000.00
Sep 30, 2021 1.03 Mn
API Access

Spruce Biosciences Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SPRB&period=max&api_key=YOUR_API_KEY